Huntsman Corporation 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated July 29, 2016, reports a material definitive agreement entered into by Huntsman Investments (Netherlands) BV (HIBV), a wholly-owned subsidiary of Huntsman Corporation. The filing discloses a strategic divestiture of the Company's European surfactants manufacturing operations.
Key Financial Metrics and Transaction Details
- Transaction Value: Enterprise value of $225 million.
- Assets Involved: Manufacturing facilities located in Saint-Mihiel, France; Castiglione delle Stiviere, Italy; and Barcelona, Spain.
- Buyer: Innospec International LTD (a subsidiary of Innospec Inc.).
- Financial Adjustments: The purchase price is subject to working capital and other adjustments. HIBV will retain accounts receivable and certain trade payables.
- Post-Transaction Arrangement: HIBV will enter into supply and long-term tolling arrangements with Innospec to continue supplying certain surfactants globally.
Material Changes and Conditions
The transaction is not yet closed and is subject to customary closing conditions, including:
- Completion of representative bodies consultation processes required by French legislation.
- Clearance by applicable competition law authorities.
- Absence of a material adverse effect on the business.
The filing does not provide specific revenue, profit, cash flow, or debt metrics for the Company or the specific assets being sold, as this is a transaction announcement rather than a periodic financial report.
Outlook, Risks, and Management Commentary
Management has committed to the sale via an Exclusivity and Put Option Agreement. The transaction includes customary representations, warranties, covenants, and indemnification rights. The filing notes that the agreements contain termination rights for both parties. A press release regarding this transaction was issued on August 3, 2016.
Key Facts for Investor Verification
- Verify the final closing date and whether all regulatory conditions (specifically French consultation and competition clearance) are satisfied.
- Confirm the final purchase price after working capital adjustments.
- Review the terms of the long-term tolling and supply agreements to assess future revenue exposure to the sold assets.
- Monitor for any material adverse changes to the business that could trigger termination rights.